Antibodies News and Research

RSS

Study shows how coronavirus variants spread more quickly

The fast-spreading UK, South Africa, and Brazil coronavirus variants are raising both concerns and questions about whether COVID-19 vaccines will protect against them.

18 Mar 2021

Risk of SARS-CoV-2 infection as UK schools reopened in 2020 was very low, say researchers

A study conducted by Public Health England has found that the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – was very low among both students and staff as primary schools partially and fully reopened over the latter half of 2020.

17 Mar 2021

New SARS-CoV-2 variant in France appears undetectable by PCR

French authorities have announced the emergence of a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the northwestern region of Brittany that has escaped detection by standard polymerase chain reaction (PCR) tests.

17 Mar 2021

Researchers develop rapid method for identifying antibody-resistant SARS-CoV-2 mutants

Researchers in the United States have described a novel rapid method for identifying antibody-resistant mutants in SARS-CoV-2.

17 Mar 2021

Can vaccination and infection rates add up to reach Covid herd immunity?

It's been a long, dark winter of Covid concerns, stoked by high post-holiday case counts and the American death tally exceeding 530,000 lives lost.

17 Mar 2021

Quantum dot-based affinity biosensors in microfluidic systems offer an alternative SARS-CoV-2 diagnostics platform

In a new study published in Emergent Materials, researchers show how microfluidic systems integrated with quantum dot-based affinity biosensors can serve as a valuable platform to rapidly and accurately diagnose SARS-CoV-2 infection.

17 Mar 2021

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

CDI Labs – a biotechnology company based in Puerto Rico – is using INTEGRA’s VIAFLO and VOYAGER electronic pipettes to streamline workflows and improve accuracy for the development of next generation proteomics products.

From INTEGRA Biosciences 17 Mar 2021

New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry

A brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy to inhibit the ability of SARS-CoV-2 to invade human cells.

17 Mar 2021

Compromised immunity can allow SARS-CoV-2 to evade the immune system

The vast majority of people infected with SARS-CoV-2 clear the virus, but those with compromised immunity--such as individuals receiving immune-suppressive drugs for autoimmune diseases--can become chronically infected.

17 Mar 2021

Living with a COVID-19 case brings worse symptoms and stronger antibody response

This study suggests that high virus exposure levels contribute to greater disease severity and stronger antibody responses. The observations from this study are published on the medRxiv preprint server.

17 Mar 2021

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

As vaccine efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease, roll out in various countries, Moderna ups the game by testing its next-generation COVID-19 vaccine.

16 Mar 2021

Salivary IgG to SARS-CoV-2 after mild COVID-19

A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine months after acquiring the disease, even if they displayed only mild symptoms.

16 Mar 2021

New Colombian SARS-CoV-2 lineage shares antibody-resistant mutations with other variants

Scientists in Colombia have identified a new highly divergent SARS-CoV-2 lineage with Spike substitutions L249S and E484K. These same mutations have convergently appeared in other mutant strains of the virus, most notably in variants of concern.

16 Mar 2021

Saliva-based testing as a method for monitoring population immunity to SARS-CoV-2 infection

Researchers in the United States have shown that saliva-based sampling could serve as an accurate and non-invasive alternative to blood sampling for monitoring people’s antibody responses following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or vaccination against the virus.

16 Mar 2021

UTHSC professor awarded $1.79 million grant to develop new amyloidosis treatment

The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center's Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled "Developing a Theranostic Immunotherapy for Systemic Amyloidosis."

16 Mar 2021

Study explores how SARS-CoV-2 mutations produce antibody resistance and enhanced transmissibility

An interesting new study deals with the effects of the natural mutations in the spike antigen of the SARS-CoV-2, the pathogen that is responsible for the ongoing coronavirus disease pandemic.

16 Mar 2021

New study tests how mutations in SARS-CoV-2 affect antibody neutralization

Using pseudoviruses with single amino acid substitutions, researchers found that mutations in SARS-CoV-2 reduce monoclonal antibody neutralization differently. However, convalescent sera samples did not lose neutralization potency many and were also effective against the B.1.1.7 (UK-derived) strain.

16 Mar 2021

New SARS-CoV-2 lineage has spread across many Brazilian states

Researchers in Brazil have identified the emergence of a new lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Brazil that has spread across multiple states in the country.

15 Mar 2021

Chimeric vaccines may provide universal protection against viruses like SARS-CoV-2

Researchers in the United States have developed “chimeric” vaccines that provided cross-protection against different strains of sarbecovirus in mice, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).

15 Mar 2021

Scientists discover how novel pathogens promote colorectal cancer development

Do BMMFs, the novel infectious agents found in dairy products and bovine sera, play a role in the development of colorectal cancer? Scientists led by Harald zur Hausen detected the pathogens in colorectal cancer patients in close proximity to tumors.

15 Mar 2021

Antibodies News and Research

Study shows how coronavirus variants spread more quickly

Risk of SARS-CoV-2 infection as UK schools reopened in 2020 was very low, say researchers

New SARS-CoV-2 variant in France appears undetectable by PCR

Researchers develop rapid method for identifying antibody-resistant SARS-CoV-2 mutants

Can vaccination and infection rates add up to reach Covid herd immunity?

Quantum dot-based affinity biosensors in microfluidic systems offer an alternative SARS-CoV-2 diagnostics platform

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

New research proposes innovative antibody-based treatment to prevent SARS-CoV-2 viral entry

Compromised immunity can allow SARS-CoV-2 to evade the immune system

Living with a COVID-19 case brings worse symptoms and stronger antibody response

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

Salivary IgG to SARS-CoV-2 after mild COVID-19

New Colombian SARS-CoV-2 lineage shares antibody-resistant mutations with other variants

Saliva-based testing as a method for monitoring population immunity to SARS-CoV-2 infection

UTHSC professor awarded $1.79 million grant to develop new amyloidosis treatment

Study explores how SARS-CoV-2 mutations produce antibody resistance and enhanced transmissibility

New study tests how mutations in SARS-CoV-2 affect antibody neutralization

New SARS-CoV-2 lineage has spread across many Brazilian states

Chimeric vaccines may provide universal protection against viruses like SARS-CoV-2

Scientists discover how novel pathogens promote colorectal cancer development

A new way of characterising biomolecules eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News